{name}
{subtitle}
A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer
city
~25 mi. (Kiel, Germany, +144 more cities)
facility
GSK Investigational Site
drug
carboplatin, +3 more drugs
drug type
chemotherapy, +2 more types
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
city
~25 mi. (Kiel, Germany, +142 more cities)
facility
Universitätsklinikum Schleswig
biomarker
del(11)(q10), +27 more biomarkers
drug
imetelstat, +1 more drug
A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
city
~25 mi. (Kiel, Germany, +156 more cities)
facility
Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 201830
biomarker
IGH-CCND1 Fusion, +1 more biomarker
drug
dexamethasone, +1 more drug
drug type
chemotherapy, +1 more type
A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies
city
~25 mi. (Kiel, Germany, +29 more cities)
facility
Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 161729
drug
chemotherapy, +1 more drug
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
city
~67 mi. (Oldenburg in Holstein, Germany, +192 more cities)
facility
Ostholstein Onkologie
biomarker
ER Positive, +1 more biomarker
drug
abemaciclib, +1 more drug
drug type
hormone therapy, +1 more type
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
city
~69 mi. (Lübeck, Germany, +226 more cities)
facility
Universitaetsklinikum Schleswig Holstein. ( Site 0346)
drug
enzalutamide, +1 more drug
drug type
hormone therapy, +1 more type
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)
city
~69 mi. (Lübeck, Germany, +140 more cities)
facility
Universitaetsklinikum Schleswig-Holstein-Campus Lubeck ( Site 0215)
drug
lenvatinib, +2 more drugs
drug type
chemotherapy, +2 more types
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)
city
~69 mi. (Lübeck, Germany, +159 more cities)
facility
Universitaetsklinikum Schleswig-Holstein-Campus Lubeck ( Site 0512)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +1 more type